
Congress trades
Insmed Incorporated (INSM)
NASDAQ · Healthcare · 10 congress trades · last filed 2 months ago
About Insmed Incorporated
from the company's filings and listing- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Chief executive
- William H. Lewis
- Employees
- 1,664
- Listed since
- Jun 1, 2000
- Market value
- $27.9B
- Price to earnings
- -
- Earnings per share
- -$4.03
- Dividend yield
- -
Earnings
6 reported quarters · next on Oct 29, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Aug 6, 2026 | -$0.06 | -$0.67 | $425.5M | $395.5M | EPS beatRevenue beat |
| Q1 FY2026reported May 7, 2026 | -$0.76 | -$0.96 | $306.0M | $300.8M | EPS beatRevenue beat |
| Q4 FY2025reported Feb 19, 2026 | -$1.54 | -$1.07 | $263.8M | $231.2M | EPS missRevenue beat |
| Q3 FY2025reported Oct 30, 2025 | -$1.75 | -$1.33 | $142.3M | $115.4M | EPS missRevenue beat |
| Q2 FY2025reported Aug 7, 2025 | -$1.70 | -$1.30 | $107.4M | $104.1M | EPS missRevenue beat |
| Q1 FY2025reported May 8, 2025 | -$1.42 | -$1.34 | $92.8M | $91.5M | EPS missRevenue in line |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Apr 1, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| William H. LewisCEO | $855K | $3.0M | $10.6M | $14.5M |
| Martina Flammer, M.D.Chief Medical Officer | $634K | $875K | $3.2M | $4.7M |
| Roger AdsettChief Operating Officer | $623K | $875K | $3.2M | $4.7M |
| Sara BonsteinChief Financial Officer | $583K | $875K | $3.2M | $4.6M |
| Michael A. SmithChief Legal Officer | $595K | $750K | $2.8M | $4.1M |
The summary compensation table from the 2025 proxy statement, current executives only. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| FMR LLC | $1.7B | 16,143,583 | +22.7% | 7.43% |
| Blackrock, Inc. | $1.7B | 15,807,984 | -5.2% | 7.27% |
| Vanguard Portfolio Management LLC | $1.1B | 10,407,962 | +0.3% | 4.79% |
| Jpmorgan Chase & Co | $1.1B | 10,428,170 | -56.8% | 4.80% |
| Vanguard Capital Management LLC | $1.0B | 9,790,865 | +1.5% | 4.50% |
| Baker Bros. Advisors LP | $937.8M | 8,796,111 | +18.5% | 4.05% |
| Capital International Investors | $878.3M | 8,238,124 | +47.2% | 3.79% |
| Darwin Global Management, Ltd. | $673.6M | 6,431,163 | -61.7% | 2.96% |
| Ameriprise Financial Inc | $658.9M | 6,179,571 | +102.1% | 2.84% |
| Orbis Allan Gray Ltd | $647.9M | 6,076,487 | +224.5% | 2.80% |
| State Street Corp | $645.3M | 6,052,174 | +9.0% | 2.78% |
| D. E. Shaw & Co., Inc. | $626.7M | 5,877,959 | +4.5% | 2.70% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
Congress trades in INSM
10 disclosures of 10 on record · median 35d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +40.2%S&P +5.1% · vs S&P 500 +35.1% | Jun 10, 2026 | Jul 7, 2026 | 27d |
| Gilbert Ray Cisneros, Jr.Filed late | Stock | Sale | $1,001 - $15,000 | -18.0%S&P +13.9% · vs S&P 500 -31.9% | Oct 3, 2025 | Nov 18, 2025 | 46d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | -11.2%S&P +14.0% · vs S&P 500 -25.2% | Sep 22, 2025 | Oct 10, 2025 | 18d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | +17.6%S&P +19.7% · vs S&P 500 -2.1% | Aug 8, 2025 | Sep 12, 2025 | 35d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | +32.9%S&P +22.8% · vs S&P 500 +10.0% | Jul 7, 2025 | Aug 14, 2025 | 38d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +26.8%S&P +26.5% · vs S&P 500 +0.3% | Jun 16, 2025 | Jul 16, 2025 | 30d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +90.7%S&P +40.4% · vs S&P 500 +50.3% | Apr 9, 2025 | May 14, 2025 | 35d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +89.4%S&P +39.7% · vs S&P 500 +49.8% | Jun 21, 2024 | Jul 9, 2024 | 18d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +168.0%S&P +43.9% · vs S&P 500 +124.1% | May 28, 2024 | Jun 8, 2024 | 11d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +578.6%S&P +93.6% · vs S&P 500 +485.0% | Dec 6, 2022 | Jan 13, 2023 | 38d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Questions
Which members of Congress have traded INSM?
Josh Gottheimer, Gilbert Ray Cisneros, Jr. disclosed INSM transactions in the filings shown here.
How quickly are INSM trades disclosed?
Congressional disclosures took a median of 35 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.
